GlassScriptPhysician profile
Francisco Jaume
NPI 1164484325
$1,642.41
in general payments reported to CMS, 2019-2025
10 companies · $42.30 in 2025
The $42.30 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $561 · 2020: $872 · 2021: $166 · 2025: $42.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $669.52 | 2020 | |
| Medical Device Business Services, INC. | $222.04 | 2019 | |
| Goode Surgical INC | $189.78 | 2020 | |
| Depuy Synthes Sales INC. | $141.41 | 2019 | |
| Organogenesis INC. | $109.00 | 2019-2020 | |
| Skeletal Dynamics INC | $102.06 | 2019 | |
| Zimmer Biomet Holdings, INC. | $90.72 | 2021 | |
| Smith+Nephew, INC. | $57.97 | 2021 | |
| Stryker Corporation | $42.30 | 2025 | |
| Vericel Corporation | $17.61 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francisco Jaume listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.